A cardiologist and an electrical engineer are trying to change the physics, chemistry and biology of investing. Can Endiya rewire the venture rules?

It’s estimated that cell therapy products will cost more than $450,000 per injection globally. The Bengaluru-based Eyestem’s mission to democratise access to such treatment by bringing the cost down to...

The recent pandemic has exposed a whole lot of shortcomings in the healthcare system here in India. I believe the most important lesson that the pandemic has taught us is...

Steradian Semiconductors, a Bengaluru-based fabless semiconductor company that providers 4D imaging radar solutions, is being acquired by Renesas Electronics Corporation, a Japanese firm that supplies advanced semiconductor solutions.

Eyestem, a Bengaluru-based cell therapy company, has raised $6.4 million (Rs 51 Crore) in a Series A round led by three pharma majors - Biological E. Limited (BE), Alkem, NATCO and Anurag...

With this acquisition, ESOP Direct and Qapita, which create and manage ESOPs of private companies, has become a combined entity that can manage over $12 Bn worth ESOPs

The investment philosophy at Endiya Partners has always been distinctive. The company invests across the SaaS, deep tech, financial services and healthcare sectors

Scrut Automation, APAC’s leading information security (infosec) compliance automation platform, launched a new product called Trust Vault as an integrated offering to its smart GRC platform.

Sigtuple’s AI100 powered screening enables efficient haematological cancer detection and disease management.

AquaExchange, tech platform to connect farmers for shrimp and fish ecosystem, has raised $3 million in Pre-Series A funding from Endiya Partners and Accion Venture Lab, with participation from existing...